Auto-Injector Issues Get Cross-Center Investigation From US FDA
Reports of bent needles and injector failures in auto-injectors filled with generics of multiple sclerosis drug Copaxone also raise questions about the FDA’s complex product approval process.
You may also be interested in...
Principal Deputy Commissioner Woodcock is overseeing an enterprise-wide technology campaign intended to improve access to agency information and data.
Senate appropriations bill would take back some of increase House offered Center for Drug Evaluation and Research and other FDA programs, setting up negotiations as start of FY2023 nears.
Furloughs would allow affected FDA staff to remain employed, while a layoffs would require affected workers to be rehired.